发明名称 |
METABOLITES OF SONIDEGIB (LDE225) |
摘要 |
<p>Provided herein are metabolites of N-(6-((2R,6S)-2,6-dimethylmorpholino)pyridin-3-yl)- 2-methyl-4'-(trifluoromethoxy)-[1,1'-biphenyl]-3-carboxamide (Sonidegib, LDE225) that modulate the activity of the Hedgehog signaling pathway and that are useful in the treatment of diseases related to activity of Hedgehog signaling pathway including, for example, cancers of the brain, muscle, skin, and prostate; medulloblastoma; pancreatic adenocarcinomas; and small-cell lung carcinomas.</p> |
申请公布号 |
WO2015092720(A1) |
申请公布日期 |
2015.06.25 |
申请号 |
WO2014IB67042 |
申请日期 |
2014.12.17 |
申请人 |
NOVARTIS AG;FREDENHAGEN, ANDREAS;KITTELMANN, MATTHIAS;PEUKERT, STEFAN;EGGIMANN, FABIAN KURT;KUEHNOEL, JUERGEN |
发明人 |
FREDENHAGEN, ANDREAS;KITTELMANN, MATTHIAS;PEUKERT, STEFAN;EGGIMANN, FABIAN KURT;KUEHNOEL, JUERGEN |
分类号 |
C07C65/34;A61K31/165;A61K31/18;A61P35/00;C07D213/72;C07D413/04;C07H13/08 |
主分类号 |
C07C65/34 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|